Hepatitis C Virus Infection Is Positively Associated with Gallstones in Liver Cirrhosis

Fen-Ming Zhang1, Li-Hua Chen, Hong-Tan Chen

  • 1Department of Gastroenterology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

Digestion
|April 20, 2016
PubMed

Insights

Gallstone disease (GD) is more common in patients with liver disease, particularly hepatitis C virus (HCV) cirrhosis. Age, female sex, and LDL-cholesterol are key risk factors for gallstones in liver disease patients.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstone disease (GD) is a common condition with multifactorial etiology.
  • Liver disease, encompassing viral hepatitis and alcohol-related liver injury, affects a significant population.
  • Understanding the interplay between liver disease and GD is crucial for comprehensive patient management.

Purpose of the Study:

  • To determine the prevalence of gallstone disease (GD) in patients with liver disease.
  • To identify risk factors associated with GD in this population.
  • To explore the relationship between the etiology and severity of liver disease and GD prevalence.

Main Methods:

  • Analysis of 4,832 patients with liver injury from hepatitis B virus (HBV), hepatitis C virus (HCV), or excessive alcohol consumption.
  • Logistic regression analysis to identify risk factors for GD.
  • Multiple logistic regression to assess the influence of liver disease etiology and severity on GD prevalence, adjusting for confounders.

Main Results:

  • Prevalence of GD was 18.6% in HBV, 22.4% in HCV, and 13.5% in alcohol-induced liver disease.
  • Independent risk factors for GD included age, female sex, LDL-cholesterol, family history, HBV, HCV, chronic hepatitis, and cirrhosis.
  • HCV-related cirrhosis showed a significantly higher association with GD (OR 2.66) compared to alcohol-related cirrhosis, especially in both genders. HBV-related cirrhosis was associated in males.

Conclusions:

  • Hepatitis C virus (HCV) infection is positively associated with gallstone formation.
  • The risk of gallstones is particularly elevated in patients with HCV-related cirrhosis.
  • Age, female sex, and lipid profiles are significant risk factors for gallstone disease in liver disease patients.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
27
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Gallbladder01:17

Gallbladder

The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
2.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
254
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K